Why Prestige Consumer Healthcare (PBH) is a Top Value Stock for the Long-Term

Core Insights - Zacks Premium offers various tools for investors to enhance their stock market strategies and confidence [1] - The Zacks Style Scores provide a framework for evaluating stocks based on value, growth, and momentum characteristics [2][3][4][5][6] Zacks Style Scores - The Style Scores categorize stocks into four types: Value Score, Growth Score, Momentum Score, and VGM Score, each focusing on different investment strategies [3][4][5][6] - Value Score emphasizes finding undervalued stocks using metrics like P/E and Price/Sales ratios [3] - Growth Score assesses stocks based on projected earnings and sales growth [4] - Momentum Score identifies stocks with favorable price trends and earnings outlooks [5] - VGM Score combines all three styles to highlight stocks with the best overall potential [6] Zacks Rank - The Zacks Rank is a proprietary model that uses earnings estimate revisions to help investors build successful portfolios [7] - Stocks rated 1 (Strong Buy) have historically outperformed the market, with an average annual return of +25.41% since 1988 [8] - There are over 800 stocks rated 1 or 2, making it essential for investors to utilize Style Scores to narrow down choices [9] Stock Example: Prestige Consumer Healthcare (PBH) - Prestige Consumer Healthcare Inc. develops and sells OTC healthcare products across various markets [11] - PBH holds a 3 (Hold) rating on the Zacks Rank and has a VGM Score of B, indicating solid potential [12] - The company has a forward P/E ratio of 17, making it attractive for value investors [12] - Recent upward revisions in earnings estimates suggest positive momentum, with the Zacks Consensus Estimate for fiscal 2026 at $4.76 per share [12] - With strong Value and VGM Style Scores, PBH is recommended for investors' consideration [13]